Igneous Bio
Subscribe
Sign in
Home
Archive
About
Latest
Top
On Biotech Interdependence
One thing I’m always interested in about each biotech I advise as they get started is how they handle metadata.
Dec 3, 2024
•
Mason Victors
Share this post
Igneous Bio
On Biotech Interdependence
Copy link
Facebook
Email
Notes
More
November 2024
On Expanding a Leadership Team
To hire from the outside or promote from within...
Nov 19, 2024
•
Mason Victors
3
Share this post
Igneous Bio
On Expanding a Leadership Team
Copy link
Facebook
Email
Notes
More
On Iteration Speed
If you’ve been reading my shared thoughts, then you’ve already heard me talk about how I see much of the world through the lens of experiments.
Nov 12, 2024
•
Mason Victors
1
Share this post
Igneous Bio
On Iteration Speed
Copy link
Facebook
Email
Notes
More
October 2024
On Technical Debt (part 2)
In reviewing my notes from my chat with my friend on technical debt, I realized that my post missed a number of key points we had discussed.
Oct 29, 2024
•
Mason Victors
1
Share this post
Igneous Bio
On Technical Debt (part 2)
Copy link
Facebook
Email
Notes
More
TechBio Spotlight - Molecule.one
A few years ago Abe Heifets and Izzy Wallach (respectively the CEO and CTO of Atomwise) pointed me towards a small Polish startup called Molecule.one…
Oct 15, 2024
•
Mason Victors
2
Share this post
Igneous Bio
TechBio Spotlight - Molecule.one
Copy link
Facebook
Email
Notes
More
On Technical Debt
I’ve created my fair share of technical debt during my career.
Oct 8, 2024
•
Mason Victors
2
Share this post
Igneous Bio
On Technical Debt
Copy link
Facebook
Email
Notes
More
TechBio Spotlight - Forcyte Bio
One of the lesser-known companies I’ve been advising for the past year is Forcyte Biotechnologies, a very early-stage biotech company spun out of UCLA…
Oct 1, 2024
•
Mason Victors
Share this post
Igneous Bio
TechBio Spotlight - Forcyte Bio
Copy link
Facebook
Email
Notes
More
September 2024
TechBio Spotlights
Highlighting Intriguing TechBio Companies Making a Difference in Drug Discovery
Sep 17, 2024
•
Mason Victors
Share this post
Igneous Bio
TechBio Spotlights
Copy link
Facebook
Email
Notes
More
On Uncertainty and Difficulty
One thing I have seen frequently with many of the biotechs I advise, as well as at Recursion where I worked for close to 8 years, is an undervaluing of…
Sep 10, 2024
•
Mason Victors
Share this post
Igneous Bio
On Uncertainty and Difficulty
Copy link
Facebook
Email
Notes
More
On Recursion's SYCAMORE Trial Readout
Disclosure: I joined Recursion in 2015 when the team was fewer than 10 people.
Sep 5, 2024
•
Mason Victors
8
Share this post
Igneous Bio
On Recursion's SYCAMORE Trial Readout
Copy link
Facebook
Email
Notes
More
August 2024
On the Recursion-Exscientia Tie-Up
Just a couple of weeks ago, Recursion announced that it had entered into a definitive agreement with Exscientia to combine business entities, creating a…
Aug 27, 2024
•
Mason Victors
6
Share this post
Igneous Bio
On the Recursion-Exscientia Tie-Up
Copy link
Facebook
Email
Notes
More
On Meta-Experiments
Call me crazy, but I don’t believe a company’s leadership team’s most important job is to deliver a positive financial outcome.
Aug 20, 2024
•
Mason Victors
1
Share this post
Igneous Bio
On Meta-Experiments
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts